Stryker in advanced talks to acquire Inari Medical - Reuters By Investing.com
- Stryker is in advanced talks to acquire Inari Medical, a company that produces devices for venous diseases, as reported by Reuters.
- If successful, the acquisition announcement could be made this week, with Stryker agreeing to pay approximately $4.9 billion for Inari Medical.
- Under the deal, Stryker would acquire all of Inari's shares for $80 per share in cash, a premium of over $30 from the closing price on Friday.
- Stryker CEO Kevin Lobo stated that Inari's innovations will elevate care standards for venous thromboembolism patients and accelerate Stryker's impact in endovascular procedures.
Insights by Ground AI
Does this summary seem wrong?
Coverage Details
Total News Sources0
Leaning Left0Leaning Right2Center2Last UpdatedBias Distribution50% Center, 50% Right
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
50% Center
C 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage